Item 2.02 Results of Operations and Financial Condition.
On May 4, 2022, CONMED Corporation ("CONMED") issued a press release announcing
financial results for the first quarter ended March 31, 2022. The press release
is attached hereto as Exhibit 99.1 and incorporated by reference herein.
The information under this Item 2.02 of this current report on Form 8-K,
including Exhibit 99.1 attached hereto, is being furnished and shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934 (as amended, the "Exchange Act") or otherwise subject to the liabilities
of that section, nor shall such information be deemed incorporated by reference
in any filing under the Securities Act of 1933 (as amended, the "Securities
Act"), or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 7.01 Regulation FD Disclosure.
On May 4, 2022, CONMED issued a press release announcing the entry into a
definitive agreement to acquire In2Bones Global, Inc. ("In2Bones"). The press
release is attached hereto as Exhibit 99.2 and incorporated by reference herein.
The information under this Item 7.01 of this current report on Form 8-K,
including Exhibit 99.2 attached hereto, is being furnished and shall not be
deemed to be "filed" for purposes of Section 18 of the Exchange Act or otherwise
subject to the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act or the Exchange
Act, except as shall be expressly set forth by specific reference in such
filing.
Cautionary Statement Regarding Forward-Looking Statements.
This current report on Form 8-K and the other documents referenced herein may
contain certain forward-looking statements (including "forward-looking
statements" within the meaning of the U.S. Private Securities Litigation Reform
Act of 1995) with respect to the financial condition, results of operations and
business of CONMED and certain plans and objectives of CONMED. All statements
other than statements of historical or current fact included in this Form 8-K
are statements that could be deemed forward-looking statements. Often, but not
always, forward-looking statements can be identified by the use of words such as
"plans," "expects," "expected," "scheduled," "estimates," "intends,"
"anticipates" or "believes," or variations of such words and phrases, or can
state that certain actions, events, conditions, circumstances or results "may,"
"could," "would," "might" or "will" be taken, occur or be achieved. These
forward-looking statements are based upon the current beliefs and expectations
of CONMED, members of its senior management team and its Board of Directors, and
are subject to certain assumptions and contingencies that involve risks and
uncertainties, including factors outside of CONMED's control. Such risks and
uncertainties contained in forward-looking statements can include, without
limitation: risks posed to CONMED's business, financial condition, and results
of operations by the COVID-19 global pandemic and the various government
responses to the pandemic, including deferral of surgeries, reductions in
hospital and ambulance surgery center operating volumes and disruption to
potential supply chain reliability; the ability of CONMED to advance In2Bones'
product lines following the merger; uncertainties as to the timing for
completion of the merger; the possibility that various conditions to complete
the merger may not be satisfied or waived; transaction costs in connection with
the merger; the potential effects of the merger on relationships with employees,
customers, other business partners or governmental entities; any assumptions
underlying any of the foregoing; as well as risk factors discussed in the
Company's Annual Report on Form 10-K for the full year ended December 31, 2021
and other risks and uncertainties which may be detailed from time to time in
reports filed by CONMED with the SEC. CONMED's shareholders and other investors
are cautioned that any such forward-looking statements are not guarantees of
future performance and to not place undue reliance on these forward-looking
statements, as actual results may differ materially from those currently
anticipated. All forward-looking statements are based on information currently
available to CONMED, and CONMED undertakes no obligation to update any such
forward-looking statements as a result of new information, future developments
or otherwise, except as expressly required by law.
--------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description of Exhibit
99.1 Press Release, dated May 4, 2022, issued by CONMED Corporation.
99.2 CONMED Announces Definitive Agreement to Acquire In2Bones Global,
Inc., dated May 4, 2022, issued by CONMED Corporation.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
CONMED CORPORATION 
